Best Deal Properties Holding p.l.c. – New Bond Issue

Best Deal Properties Holding P.L.C.  (the “Issuer”), is pleased to announce the issue of €15,000,000 Secured bonds at 4.75% at a nominal value of €100 per bond, redeemable in 2025 or 2027 (the “Bond Issue”), following approval by the Listing Authority.

This bond issue will be subject to a minimum of €5,000, and will be issued at par. The interest rate of 4.75 per cent will be paid annually on 30 November as from 30 November 2023 (the first interest payment date).

The use of the bond proceeds will consist of:

  • the amount of circa €10.2 million for the purposes of funding the acquisition of a site in Siġġiewi, and other related costs of acquisition; and
  • the amount of circa €4.4 million shall be retained by the Security Trustee to be disbursed to contractors, engaged to undertake excavation and construction works relating to the Siġġiewi development, once the Siġġiewi Site is acquired as indicated above.

Full details about this Bond Issue are set out in the Prospectus dated 9th November 2022 which can be found here.

MeDirect will be accepting applications from anyone, who is interested. All applications must be received by not later 25th November 2022. In the event of over-subscription, the Issuer reserves the right to close the Offer Period before this date.

If you are interested in applying, please send us a Secure Mail or contact your Relationship Manager.

For further information, please call us on (+356) 2557 4400 or send an email to customerservice@medirect.com.mt.

_____

 

The information set forth in this article is only for informative purposes and should not be construed as an offer to sell or solicitation of an offer to subscribe for or purchase any investment. The information provided is subject to change without notice and does not constitute investment advice or any guarantee of returns.

Please consider the terms and conditions governing the relevant investment prior to making any investment decision. Investors should note that at worst they may lose all of their invested principal in the event of default, insolvency and/or bankruptcy of the relevant issue. The financial instruments discussed may not be suitable for all investors and investors must make their own informed decisions and seek their own advice regarding the appropriateness of investing in financial instruments or implementing strategies discussed herein.

MeDirect Bank (Malta) plc has based this document on information obtained from sources it believes to be reliable but which have not been independently verified. MeDirect Bank (Malta) plc does not therefore provide any guarantees, representations or warranties. The value of any investment or income may go up as well as down and past performance is no guarantee of any future performance. When an investment is denominated in a currency other than your local or reporting currency, changes in exchange rates may have an adverse effect on your investment.

MeDirect Bank (Malta) plc, company registration number C34125, is licensed by the Malta Financial Services Authority under the Banking Act (Cap. 371) and the Investment Services Act (Cap. 370). This material is intended only for the use of the recipient and shall not be reproduced in any way, whether in whole or in part, by the recipient. Any unauthorised disclosure, use or dissemination, either in whole or in part, of the material contained within is strictly prohibited.

Blue Whale Capital’s Stephen Yiu to address medirectalk

Following several webinars held during the pandemic, MeDirect Bank Malta will host its fifteenth medirectalk, which will finally see the return of the in-person seminars. medirectalk is a series of seminars organised by MeDirect Bank featuring several financial experts and asset managers sharing their views on market and investment opportunities. This upcoming medirectalk event will be held at the Hyatt Regency Hotel in St Julian’s on Wednesday, November 30th, at 18:00Hrs.

This seminar will be in collaboration with The Blue Whale Growth Fund, a global equity fund, focusing on large-cap stocks in developed markets. The strategy was launched in September 2017 and since inception it is one of the best performing funds in the IA Global sector.

Titled “A Blank Piece of Paper”, the seminar will feature Stephen Yiu as the keynote guest speaker. Stephen Yiu is the Chief Investment Officer at Blue Whale Capital and Lead Manager of the Blue Whale Growth Fund. In 2016, Mr. Yiu and Peter Hargreaves, co-founder of Hargreaves Lansdown, co-founded Blue Whale Capital. The Blue Whale Growth Fund (UCITS), available for Maltese customers was launched in September 2020, following the original launch of the LF Blue Whale Growth Fund in 2017, and is a long-only global equity fund focusing on developed markets. Stephen adopts a high conviction, active approach based on bottom-up, fundamental research.

Mr. Yiu will be giving an update on the Blue Whale Growth Fund and the investment markets in general. He will also be discussing some specific economic sectors and the reasons behind investing in equities within these segments.

Following the talk, there will be a question-and-answer session during which Stephen will be open to answer any questions from those in attendance. At the end of the evening, drinks and canapés will be served, and Mr You, together withMeDirect advisors will be available to answer any remaining questions.

Registration for the event is required by visiting https://promo.medirect.com.mt/medirectalk-november2022/, however participation is free of charge.

Live streaming will be available for those unable to attend in person through MeDirect Bank Malta’s Facebook page. Further information on medirectalk can be found here: https://medirect.com.mt/invest/medirectalk


The speakers themselves, personally or on behalf of the institutions they are representing, are not responsible for the opinions they express during the discussions.

The information given during these talks is for general information purposes only and is neither intended to provide legal or other professional advice nor does it commit MeDirect Bank (Malta) plc to any obligation whatsoever. The information given during the talks is not intended to be a suggestion, recommendation or solicitation to buy, hold or sell, any securities and is not guaranteed as to accuracy or completeness. The financial instruments discussed may not be suitable for all investors and investors must make their own informed decisions and seek their own advice regarding the appropriateness of investing in financial instruments or implementing strategies discussed herein.

MeDirect Bank (Malta) plc, company registration number C34125, is licensed to undertake the business of banking in terms of the Banking Act (Cap. 371) and investment services under the Investment Services Act (Cap. 370). MeDirect Bank (Malta) plc is regulated by the Malta Financial Services Authority as a Credit Institution under the Banking Act 1994.

You are leaving medirect.com.mt

Please be aware that the external site policies, or those of another MeDirect website, may differ from this website’s terms and conditions and privacy policy. The next website will open in a new browser window or tab.

 

Note: MeDirect is not responsible for any content on third party sites, nor does a link suggest endorsement of those sites and/or their content.

Login

We strive to ensure a streamlined account opening process, via a structured and clear set of requirements and personalised assistance during the initial communication stages. If you are interested in opening a corporate account with MeDirect, please complete an Account Opening Information Questionnaire and send it to corporate@medirect.com.mt.

For a comprehensive list of documentation required to open a corporate account please contact us by email at corporate@medirect.com.mt or by phone on (+356) 2557 4444.